Stock Research for GENE


Featured Broker: Ally Invest

Get the due diligence for another stock.


GENE Stock Chart & Research Data

The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


GENE Due diligence Resources & Stock Charts

The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GENE Detailed Price Forecast - CNN Money CNN View GENE Detailed Summary - Google Finance
Yahoo View GENE Detailed Summary - Yahoo! Finance Zacks View GENE Stock Research & Analysis -

Stock Analysis

TradeIdeas View GENE Trends & Analysis - Trade-Ideas Barrons View GENE Major Holders - Barrons
NASDAQ View GENE Call Transcripts - NASDAQ Seeking View GENE Breaking News & Analysis - Seeking Alpha
Spotlight View GENE Annual Report - OTC Report View GENE OTC Short Report -
TradeKing View GENE Fundamentals - TradeKing Charts View GENE SEC Filings - Bar Chart
WSJ View Historical Prices for GENE - The WSJ Morningstar View Performance/Total Return for GENE - Morningstar
MarketWatch View the Analyst Estimates for GENE - MarketWatch CNBC View the Earnings History for GENE - CNBC
StockMarketWatch View the GENE Earnings - StockMarketWatch MacroAxis View GENE Buy or Sell Recommendations - MacroAxis
Bullish View the GENE Bullish Patterns - American Bulls Short Pains View GENE Short Pain Metrics -

Social Media Mentions

StockTwits View GENE Stock Mentions - StockTwits PennyStocks View GENE Stock Mentions - PennyStockTweets
Twitter View GENE Stock Mentions - Twitter Invest Hub View GENE Investment Forum News - Investor Hub
Yahoo View GENE Stock Mentions - Yahoo! Message Board Seeking Alpha View GENE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for GENE - Insider Cow View Insider Transactions for GENE - Insider Cow
CNBC View GENE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GENE - OTC Markets
Yahoo View Insider Transactions for GENE - Yahoo! Finance NASDAQ View Institutional Holdings for GENE - NASDAQ

Stock Charts

FinViz View GENE Stock Insight & Charts - StockCharts View GENE Investment Charts -
BarChart View GENE Stock Overview & Charts - BarChart Trading View View GENE User Generated Charts - Trading View

Latest Financial News for GENE

Genetic Technologies Invited to Establish a Market Presence in Hainan, China
Posted on Monday September 17, 2018

MELBOURNE, Australia, Sept. 17, 2018-- Hainan Resort Software Community has on behalf of Hainan Ecological Smart City Group formally extended an invitation to Genetic Technologies Limited to establish ...

Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China
Posted on Tuesday August 21, 2018

MELBOURNE, Australia, Aug. 21, 2018-- Representatives of the Hainan Government- Hainan Ecological Smart City Group, a Chinese industrial park development & operations company have formally invited Genetic ...

Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited
Posted on Thursday August 16, 2018

Nasdaq: GENE, “Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, is pleased to announce that it has signed a Heads of Agreement (Agreement) with Beijing Zishan Health Consultancy Limited (Zishan). Zishan will take on the functions of sales, account management, marketing and promotion of GTG’s genetic risk assessment products for the Chinese market.

Genetic Technologies Secures A$20 Million Equity Placement Facility
Posted on Wednesday August 08, 2018

Nasdaq: GENE, “Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, is pleased to announce that it has entered into a A$20 million Equity Placement Facility (the “Facility”) with the Kentgrove Capital Growth Fund (“Kentgrove Capital”), an investment fund managed by Kentgrove Capital Pty Ltd, a Melbourne-based investment management firm, to strengthen the Company’s funding position. Under the Facility, Kentgrove Capital may provide the Company with up to A$20 million of equity capital in a series of individual placements of up to $1 million (or a higher amount by mutual agreement) over the next 20 months.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.